ArticleACS pharmacology & translational science2024
Chromatin Licensing and DNA Replication Factor 1 (CDT1) Is a Potential Prognostic Biomarker Involved in the Malignant Biological Behavior of Glioma.
Tiange Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.